The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2014
Filed:
Mar. 07, 2012
Applicants:
Thomas Boehme, Frankfurt am Main, DE;
Christian Engel, Frankfurt am Main, DE;
Stefan Guessregen, Frankfurt am Main, DE;
Torsten Haack, Frankfurt am Main, DE;
Gerhard Kretzschmar, Frankfurt am Main, DE;
Kurt Ritter, Frankfurt am Main, DE;
Georg Tschank, Frankfurt am Main, DE;
Inventors:
Thomas Boehme, Frankfurt am Main, DE;
Christian Engel, Frankfurt am Main, DE;
Stefan Guessregen, Frankfurt am Main, DE;
Torsten Haack, Frankfurt am Main, DE;
Gerhard Kretzschmar, Frankfurt am Main, DE;
Kurt Ritter, Frankfurt am Main, DE;
Georg Tschank, Frankfurt am Main, DE;
Assignee:
Sanofi, Paris, FR;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/51 (2006.01); C07D 291/08 (2006.01); C07D 515/04 (2006.01); A61K 31/5415 (2006.01); A61K 31/55 (2006.01); A61K 31/69 (2006.01); A61K 45/06 (2006.01); C07D 419/12 (2006.01); C07F 5/02 (2006.01);
U.S. Cl.
CPC ...
C07D 291/08 (2013.01); C07D 515/04 (2013.01); A61K 31/5415 (2013.01); A61K 31/55 (2013.01); A61K 31/69 (2013.01); A61K 45/06 (2013.01); C07D 419/12 (2013.01); C07F 5/027 (2013.01);
Abstract
The invention relates to the compounds of formula (I) and physiologically acceptable salts thereof. The compounds are suitable, e.g., for treating hyperglycemia.